MTARC1 and metabolic dysfunction-associated steatotic liver disease: It has been shown that MARC1 deficiency can protect against cirrhosis [11] and decrease the severity of nonalcoholic fatty liver disease (NAFLD); however, the mechanism involved is unclear [9,12,13].